Respiratory Distress Syndrome, Newborn: all 1,179 studies
Page 6 of 12. Open to participants first (160), then studies with results posted, then the rest; newest registration first within each.
- Fenofibrate for Patients With COVID-19 Requiring HospitalizationStatus unknownNCT04661930Phase 3
- Lung Ultrasound Score and Pediatric Intensive Care Outcomes (LUS-PICO)CompletedNCT04660448
- RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot StudyStatus unknownNCT04659460Not applicable
- Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19CompletedNCT04659109Phase 2
- Impact of Decreasing Respiratory Rate on Lung Injury Biomarkers in ARDS PatientsCompletedNCT04641897Not applicable
- Effects of Extravascular Lung Water on Prone Position Efficacy in Patients With ARDSStatus unknownNCT04635267
- Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress SyndromeCompletedNCT04625738Phase 2
- Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19CompletedNCT04619368
- Role of Lung Ultrasonography in Prediction of the Seveity and the Need for Surfactant Administration in Neonates With Respiratory Distress SyndromeStatus unknownNCT04618627
- SILtuximab in Viral ARds (SILVAR) StudyTerminatedNCT04616586Phase 3
- Diaphragm Dysfunction in ARDS Patients With V-V ECMOTerminatedNCT04613752Not applicable
- Assessing the Role of Inclined Positioning in Acute Respiratory Distress Syndrome Patients RecoveryCompletedNCT04612608Not applicable
- Study to Find the Highest Safe Dose of Soluble Guanylate Cyclase (sGC) Activator, BAY 1211163 Administered as Multiple Doses by Inhalation to Patients Who Cannot Breathe by Their Own and Suffer From a Type of Lung Failure That Causes Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)TerminatedNCT04609943Phase 1
- Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 PandemiaTerminatedNCT04609865Phase 3
- PRONing to Facilitate Weaning From ECMO in Patients With Refractory Acute Respiratory Distress SyndromeCompletedNCT04607551Not applicable
- Mechanism of Delayed Neutrophil Apoptosis in Acute Lung InjuryCompletedNCT04607434
- Electrical Impedance Tomography Monitoring and Invasive Mechanical Ventilation During Pronation in Acute Respiratory Distress Syndrome.Status unknownNCT04605133
- Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04603755
- A Clinical Study of Mesenchymal Stem Cell Exosomes Nebulizer for the Treatment of ARDSCompletedNCT04602104Phase 1/2
- Survival Rates and Longterm Outcomes After COVID-19CompletedNCT04601090
- Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress SyndromeStatus unknownNCT04597853
- The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19WithdrawnNCT04588441Phase 2
- Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19Status unknownNCT04586114
- Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICUCompletedNCT04569266Not applicable
- Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19Status unknownNCT04568018
- Pre-operative Carriage of Respiratory VIRUSes, and Acute Respiratory Distress Syndrome After Heart SurgeryCompletedNCT04562207Not applicable
- Use of Extracorporeal CO2 Removal in Case of Moderate to Severe ARDS to Apply an Ultraprotective Mechanical Ventilation StrategyTerminatedNCT04556578Not applicable
- Study of Biomarkers in Patients of Sepsis Complicated With Acute Respiratory Distress Syndrome (ARDS)Status unknownNCT04552821
- Cerebral Autoregulation in Pediatric ECMO (ECMOX 2)CompletedNCT04548739
- Effect of R-spondin3 on Sepsis Induced Endothelial DysfunctionStatus unknownNCT04546919
- Earliest Lung Ultrasound Time for Predicting the Need of SurfactantCompletedNCT04544514
- Radiomics Markers to Predict Sepsis Induced Acute Respiratory Distress SyndromeStatus unknownNCT04541264
- The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying CauseCompletedNCT04537351Phase 1
- Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)CompletedNCT04534569
- MSC-based Therapy in COVID-19-associated Acute Respiratory Distress SyndromeStatus unknownNCT04525378Phase 1
- COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2Status unknownNCT04524156Not applicable
- Blood Volume Assessment in COVID-19 and Bacterial SepsisCompletedNCT04517695
- Coronavirus Studied by Metagenomics in ARDS COVID-19 PatientsStatus unknownNCT04516486
- Telmisartan in Respiratory Failure Due to COVID-19CompletedNCT04510662Phase 2
- Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and "Typical"ARDS PatientsWithdrawnNCT04508933
- Helmet vs Face Mask in Patients With Acute Respiratory Distress SyndromeStatus unknownNCT04507802Not applicable
- The Accuracy of Pediatric Air Test as a Non-invasive Atelectasis Diagnostic ToolCompletedNCT04506203Not applicable
- Comparison of the Results of Transcutaneous Carbon Dioxide and Oxygen Pressure in Premature Neonates Who Underwent MIST Under HHHFNC or Nasal CPAP MethodsStatus unknownNCT04505176
- Effects of End-expiratory Positive Pressure Optimization in Intubated Patients With Healthy Lung or Acute Respiratory Distress SyndromeStatus unknownNCT04503876Not applicable
- Routine Or Selective Application of a Face Mask for Preterm Infants at Birth: the ROSA TrialCompletedNCT04500353Not applicable
- Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19WithdrawnNCT04490486Phase 1
- Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDSWithdrawnNCT04482712Phase 1/2
- Safety and Effectiveness Assessment of the MakAir Artificial VentilatorTerminatedNCT04475185Not applicable
- Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 InfectionCompletedNCT04475068
- Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance TomographyCompletedNCT04473300
- Assessment of Preload Responsiveness in ARDS Patients During Prone PositionCompletedNCT04457739
- One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19CompletedNCT04457505
- Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19Active, not recruitingNCT04456361Early Phase 1
- Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)WithdrawnNCT04453371Phase 3
- Study of Decidual Stromal Cells to Treat COVID-19 Respiratory FailureCompletedNCT04451291Not applicable
- Knowledge, Attitude and Practice of Dental Students About COVID-19CompletedNCT04449081
- Comparison of Esophageal and Central Venous Pressure for Estimating Transpulmonary Pressure ChangesCompletedNCT04443491
- Effectiveness of Convalescent Immune Plasma TherapyCompletedNCT04442958Not applicable
- Chest Physiotherapy in Tracheotomized PatientsCompletedNCT04435535Not applicable
- Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19Status unknownNCT04435353Not applicable
- Physical Rehabilitation in ICU in ARDS Patients With COVID-19CompletedNCT04435080
- Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).TerminatedNCT04433546Phase 2
- This Study Collects Information on the Safety of Inhaled Pegylated Adrenomedullin (PEG-ADM), How the Drug is Tolerated and How it Affects Patients Suffering From a Type of Lung Failure That Cause Fluid to Build up in the Lungs Making Breathing Difficult (ARDS)TerminatedNCT04417036Phase 2
- Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19Status unknownNCT04416139Phase 2
- Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 DiseaseStatus unknownNCT04412395Phase 2
- Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04411459
- Impact of Respiratory Virus in Critically Ill Patients With Acute Respiratory FailureStatus unknownNCT04411368
- The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA/MIST)Status unknownNCT04409665Phase 1
- Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress SyndromeStatus unknownNCT04408326
- Surfactant Administration Via Thin Catheter Using a Specially Adapted Video Laryngoscope - the VISUAL MethodCompletedNCT04406142Not applicable
- Effects of Non-invasive Ventilation With Helium-oxygen Mixture in Premature Infants With Respiratory Distress SyndromeCompletedNCT04404816Phase 1/2
- CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04404426Not applicable
- Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)CompletedNCT04402840Not applicable
- Effectiveness of Bubble Nasal Continuous Positive Airway Pressure (bCPAP) in Neonatal Respiratory DistressCompletedNCT04401696Not applicable
- Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium NitriteWithdrawnNCT04401527Phase 2
- Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress SyndromeCompletedNCT04400032Phase 1/2
- A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE)Status unknownNCT04395456Phase 2
- COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEssCompletedNCT04395144Not applicable
- Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical TrialTerminatedNCT04395105Phase 3
- Cerebral and Circulatory Effects of Neonatal Volume Targeted VentilationCompletedNCT04391634Not applicable
- Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDSStatus unknownNCT04391140Not applicable
- Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19TerminatedNCT04390152Phase 1/2
- Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19CompletedNCT04390139Phase 1/2
- Predictors of Severe COVID-19 OutcomesCompletedNCT04388813
- Maneuver for Evaluating the Potential Recruitability of the Pulmonary Parenchyme in Patients With ARDSStatus unknownNCT04387669
- Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19.CompletedNCT04386720
- Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICUStatus unknownNCT04385004
- Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19Status unknownNCT04384731Phase 2
- Zofin (Organicell Flow) for Patients With COVID-19CompletedNCT04384445Phase 1/2
- Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19)CompletedNCT04383730
- Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress SyndromeCompletedNCT04383678
- Rehabilitation for People With COVID-19 in ICUCompletedNCT04381338Not applicable
- Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress SyndromeStatus unknownNCT04380935Phase 2/3
- A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other CausesCompletedNCT04378920Phase 1/2
- Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICUCompletedNCT04378582
- CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19WithdrawnNCT04378244Phase 1/2
- Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19)CompletedNCT04376905
- Human Ab Response & immunoMONItoring of COVID-19 PatientsCompletedNCT04373200Not applicable
- MSCs in COVID-19 ARDSTerminatedNCT04371393Phase 3
- Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19CompletedNCT04370249